ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 239

Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients

Annelies Blanken1, Marian van Beers-Tas1, Marlies Meursinge Reynders1 and Dirkjan van Schaardenburg1,2, 1Amsterdam Rheumatology and immunology Center | Reade, Amsterdam, Netherlands, 2Amsterdam Rheumatology and immunology Center | Academic Medical Center, Amsterdam, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: anti-CCP antibodies, Arthritis and ultrasound, Rheumatoid Factor

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 5, 2017

Title: Imaging of Rheumatic Diseases Poster I

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose:

Early diagnosis of rheumatoid arthritis (RA) is important for controlling disease activity and preventing joint damage. Individuals positive for anticitrullinated protein antibodies (ACPA) and/or rheumatoid factor (RF) are at risk of developing RA. In this study we investigated whether ultrasound (US) can predict development of arthritis in seropositive arthralgia patients.

Methods:

We included ACPA and/or RF positive patients with arthralgia, but without clinical arthritis. US was performed at baseline in 12 joints: bilateral MCP2-3, PIP2-3, wrist and MTP5. Images were scored semiquantitatively for synovitis and Power Doppler (PD) on a scale of 0-3. Grades 2 to 3 for synovitis and grades 1 to 3 for PD were regarded as abnormal. The association of ultrasound abnormalities with the development of arthritis was analyzed using Fisher’s exact test, expressed as odds ratios (OR) with 95% confidence interval (CI). Kaplan Meier survival analysis with log-rank test and Cox regression analysis were used to assess the timing of arthritis development, expressed as median time to arthritis and hazard ratios (HR) with 95% CI.

Results:

In total, 169 seropositive arthralgia patients underwent US examination. Mean age was 51 (standard deviation (SD) 11) and 73% was female. Of these patients, 44 (22%) developed arthritis during a mean follow-up time of 27 (SD 19) months. Thirty seven (84%) patients developing arthritis satisfied the 2010 ACR/EULAR classification criteria for RA. Synovitis and PD signal in at least one joint was observed in 14 (8%) and 7 (4%) patients, respectively. The presence of synovitis was associated with arthritis development  (OR  8.9, CI 2.6-30.2, p<.01, Table 1), whereas the presence of PD signal was not (OR 1.1, CI 0.2-6.1, p=1.0). Corresponding positive predictive values were 71% and 29%, respectively. Patients with synovitis or PD in at least one joint developed arthritis earlier than patients without US abnormalities (synovitis: median time to arthritis 11 versus 14 months, p<0.01; PD: median time to arthritis 5 versus 12 months, p<0.01; Fig 1) with corresponding HRs of 3.5 (CI 1.5-7.9, p<0.01) and 6.9 (CI 1.5-32.2, p<0.02) respectively.

Conclusion:

Synovitis on US predicted arthritis development in seropositive arthralgia patients. This association was not found for PD, however PD frequency was low and therefore the power to predict arthritis was low. However, when taking into account the time to arthritis development, both synovitis and PD were associated with an increased hazard on developing arthritis.


Figure 1. Kaplan-Meier survival curve for (A) synovitis and (B) Power Doppler (PD) and arthritis development

 


Disclosure: A. Blanken, None; M. van Beers-Tas, None; M. Meursinge Reynders, None; D. van Schaardenburg, None.

To cite this abstract in AMA style:

Blanken A, van Beers-Tas M, Meursinge Reynders M, van Schaardenburg D. Ultrasound Abnormalities Predict Arthritis Development in ACPA and/or RF Positive Arthralgia Patients [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasound-abnormalities-predict-arthritis-development-in-acpa-andor-rf-positive-arthralgia-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasound-abnormalities-predict-arthritis-development-in-acpa-andor-rf-positive-arthralgia-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology